These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 4320033)
1. induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent, 4 (5)-(3,3-dimethyl-1-triazeno) imidazole-5 (4)-carboxamide. Skibba JL; Ertürk E; Bryan GT Cancer; 1970 Nov; 26(5):1000-5. PubMed ID: 4320033 [No Abstract] [Full Text] [Related]
2. Carcinogenicity of the antineoplastic agent, 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide, and its metabolites in rats. Beal DD; Skibba JL; Croft WA; Cohen SM; Bryan GT J Natl Cancer Inst; 1975 Apr; 54(4):951-7. PubMed ID: 1127724 [TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] acetamide in female rats. Ertürk E; Cohen SM; Bryan GT Cancer Res; 1970 Apr; 30(4):936-41. PubMed ID: 4323354 [No Abstract] [Full Text] [Related]
4. Comparative carcinogenicity in the rat of 2-hydrazinothiazoles with nitrofuryl, nitrophenyl, or aminophenyl substituents in the 4-position. Cohen SM; Ertürk E; Price JM; Bryan GT Cancer Res; 1970 Apr; 30(4):897-901. PubMed ID: 5537322 [No Abstract] [Full Text] [Related]
5. Nitrosomethylurea-induced lymphomas in thymectomized mice, in relation to thymus-dependent and independent systems. Palestro G; Stramignoni A Oncology; 1975; 31(2):115-22. PubMed ID: 1082116 [No Abstract] [Full Text] [Related]
6. Study of the potential carcinogenicity of topical drug. Suggestions for a new experimental approach. Cioli V; Scorza Barcellona P; Silvestrini B Exp Mol Pathol; 1971 Aug; 15(1):1-20. PubMed ID: 4934888 [No Abstract] [Full Text] [Related]
7. Thymic lymphoma and myeloid leukemia in the rat induced with ethylnitrosourea. Hadjiolov D Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 77(2):98-100. PubMed ID: 4260571 [No Abstract] [Full Text] [Related]
8. [Features of the carcinogenic effect of 3,3'-benzidine dicarboxylic acid]. Pliss GB Vopr Onkol; 1969; 15(5):60-4. PubMed ID: 4311753 [No Abstract] [Full Text] [Related]
9. A study of thymic lymphosarcoma developing in magnesium-deficient rats. Bois P; Sandborn EB; Messier PE Cancer Res; 1969 Apr; 29(4):763-75. PubMed ID: 5251702 [No Abstract] [Full Text] [Related]
10. Pathogenesis of lymphoid neoplasia in cats and its relationship to immunologic cell pathways. I. Morphologic aspects. Mackey LJ; Jarrett WF J Natl Cancer Inst; 1972 Sep; 49(3):853-65. PubMed ID: 4678725 [No Abstract] [Full Text] [Related]
11. Carcinogenicity of formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]-hydrazide in Swiss mice. Cohen SM; Ertürk E; Bryan GT Cancer Res; 1970 Apr; 30(4):906-12. PubMed ID: 4324549 [No Abstract] [Full Text] [Related]
12. [Examination of polyvinylpyridine-N-oxide (PVNO) on the carcinogenic effect in rats and mice]. Schmähl D Arzneimittelforschung; 1969 Aug; 19(8):1313-4. PubMed ID: 4897402 [No Abstract] [Full Text] [Related]
13. Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour. Williams JC; Gusterson BA; Coombes RC Br J Cancer; 1982 Apr; 45(4):588-97. PubMed ID: 7073949 [TBL] [Abstract][Full Text] [Related]
14. Carcinogenicity of benzotrichloride administered to mice by gastric intubation. Fukuda K; Matsushita H; Takemoto K; Toya T Ind Health; 1993; 31(3):127-31. PubMed ID: 8262817 [TBL] [Abstract][Full Text] [Related]